Charcot Marie Tooth Disease
10
4
4
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
TREMOR IN CHARCOT-MARIE-TOOTH
Observational Study to Observe Variations of Gait Parameters in Patients With Neuromuscular Diseases
Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
Genotype/Phenotype Correlation of MORC2 Mutations
Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)
Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease
Development and Validation of a Disability Severity Index for CMT
Evaluation of the Analgesic Efficiency of the Transcutaneous Neurostimulation in the Charcot Syndrome Marie Tooth on the Pains of Lower Limbs
Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease